-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Aerie Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2016 to Q1 2022.
- Aerie Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was -$357K, a 67.6% increase year-over-year.
- Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.97M.
- Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$859K, a 100% decline from 2019.
- Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2019 was $275M, a 101% increase from 2018.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)